
Janssen, BMS, and Pfizer round out the top three

Janssen, BMS, and Pfizer round out the top three

Specialty and home delivery pharmacy updates name, commits to prioritizing patients

Six engagement tips for companies to consider to improve patient use of portals

An actionable perspective on the future of specialty drug value-based contracting

The Health System Owned Specialty Pharmacy (HOSP) Alliance‘s Melissa Goff responds to the news of the FTC investigation into PBM practices news and outlines the alliance‘s vision for the integrated specialty pharmacy industry

Three key objectives in building effective support programs

Endeavor aims to tackle diversity obstacles surrounding this segment, while improving the patient experience

The clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials

Questions pharmacies should ask when choosing the right proof-of-delivery solution


Organizations can go a long way toward ushering in the pharmacy of the future and enabling safer, more efficient care by implementing an intelligent infrastructure of technology.

How has the provider-patient relationship transformed over the past two years, and what care are consumers craving?

New C-Suite position emerges for more emphasis on patient centricity

Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible

Assessing the efficacy of patient support programs is the first step to optimizing their resource allocation and program design for maximized patient benefit.

Ongoing challenges—ranging from the growing complexity of today’s advanced therapy options, to inherent shortcomings in the clinical trial process, to ongoing adherence challenges and more—must be reconciled to ensure both clinical and commercial success throughout cancer care

Biopharma sponsorship of patient-support programs and treatments for rare diseases is growing, but gaps remain

New book attempts to cut through pharma’s patient-centric posturing and start a conversation about real, transformational change

Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market

The patient-first, pharmacy-first hub model optimizes outcomes and improves care journey for patients with rare disease

Disruption is the order of the day to create a more individual-centric hub experience from the patient’s point of view

A conversation with Ian Riches, head of patient solutions for Europe, Ashfield Engage

The need for supporting services in copay accumulator and best price areas

Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies

It's time to include hubs in the patient treatment journey